Clinical trial
Single Low-dose Primaquine Efficacy and Safety for Treatment of Uncomplicated Plasmodium Falciparum Malaria Based on Cytochrome P450 2D6 Activity in Bagamoyo District, Tanzania.
NCT03352843 is registered in ClinicalTrials.gov with Tropical Pesticides Research Institute, Tanzania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Low-dose Primaquine Efficacy and Safety for Treatment of Uncomplicated Plasmodium Falciparum Malaria Based on Cytochrome P450 2D6 Activity in Bagamoyo District, Tanzania.
- Lead sponsor
- Tropical Pesticides Research Institute, Tanzania
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 11, 2019
- Completion date
- February 28, 2020
- Enrollment
- 157 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.